Boxed Warning Added To Gadolinium Contrast Agents For MRI On Risk Of Potentially Fatal Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
Updated labeling for five such agents follows reports of nephrogenic systemic fibrosis after administration.